Kevin P. Callahan
- Hematology top 2%
- Acute Myeloid Leukemia Research 5
- Cancer Research top 5%
- Molecular Biology top 10%
- RNA Research and Splicing 4
- RNA and protein synthesis mechanisms 3
- Internal Medicine top 10%
- Genetics top 10%
-
- Antiplatelet Therapy and Cardiovascular Diseases 8
- Acute Myocardial Infarction Research 5
-
- Coronary Interventions and Diagnostics 5
-
- Innovative Teaching Methods 2
-
- Retinal Diseases and Treatments 2
- Co-authors
- J. Scott ButlerEleni D. LagadinouCraig T. JordanMichael W. BeckerJane L. LiesveldMohammad MinhajuddinValerie GrosePaul S. Brookes
- Journals
- Blood (3 papers)Journal of the American College of Cardiology (2 papers)Investigative Ophthalmology & Visual Science (2 papers)
- Partner nations
- United StatesSwitzerlandDenmark
In The Last Decade
Kevin P. Callahan
28 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Hematology 523
- Cancer Research 320
- Molecular Biology 1.0k
- Internal Medicine 38
- Genetics 90
Countries citing papers authored by Kevin P. Callahan
This map shows the geographic impact of Kevin P. Callahan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin P. Callahan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin P. Callahan more than expected).
Fields of papers citing papers by Kevin P. Callahan
This network shows the impact of papers produced by Kevin P. Callahan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin P. Callahan. The network helps show where Kevin P. Callahan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kevin P. Callahan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2020 | 0 | |
| 3 | 2014 | 31 | |
| 4 | 2013 | 6 | |
| 5 | BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cellsbreakdown → | 2013 | 943 |
| 6 | 2012 | 3 | |
| 7 | 2009 | 84 | |
| 8 | 2008 | 4 | |
| 9 | 2008 | 84 | |
| 10 | 2005 | 6 | |
| 11 | Retinal Function 10 Months After Intraocular or Periocular Injection of AAV-CBA-PEDF | 2003 | 2 |
| 12 | 2003 | 2 | |
| 13 | 2003 | 21 | |
| 14 | 2003 | 36 | |
| 15 | 2002 | 3 | |
| 16 | 2002 | 29 | |
| 17 | 2001 | 4 | |
| 18 | 2001 | 7 | |
| 19 | 1994 | 13 | |
| 20 | 1992 | 1 |
About Kevin P. Callahan
Kevin P. Callahan is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Internal Medicine, having authored 29 papers that have together received 1.5k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (8 papers), Acute Myeloid Leukemia Research (5 papers), Coronary Interventions and Diagnostics (5 papers), Acute Myocardial Infarction Research (5 papers), RNA Research and Splicing (4 papers), RNA and protein synthesis mechanisms (3 papers), Innovative Teaching Methods (2 papers) and Retinal Diseases and Treatments (2 papers). The work is most often cited by research in Hematology (523 citations), Cancer Research (320 citations) and Molecular Biology (1.0k citations). Kevin P. Callahan has collaborated with scholars based in United States, Switzerland and Denmark. Frequent co-authors include J. Scott Butler, Eleni D. Lagadinou, Craig T. Jordan, Michael W. Becker, Jane L. Liesveld, Mohammad Minhajuddin, Valerie Grose, Paul S. Brookes, Kristen M. O’Dwyer and Sarah J. Neering. Their work appears in journals such as Blood, Journal of the American College of Cardiology, Investigative Ophthalmology & Visual Science, The FASEB Journal and Tellus B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.